Symkevi Read about Symkevi, which combines ivacaftor with tezacaftor, and find out how the drug could help to treat people with cystic fibrosis (CF).
Orkambi Orkambi (ivacaftor/lumacaftor) is the second precision medicine to be licensed for use in the UK by people with cystic fibrosis (CF).
Kalydeco Kalydeco is the first precision medicine for cystic fibrosis (CF) to be made available on the NHS.
Support our campaigns We are here to shout loud and campaign hard for better care and services for people with cystic fibrosis (CF) - join us!
Your support changes lives Take a look at how your support this Christmas is helping to fund ground-breaking cystic fibrosis research.
Lungs and cystic fibrosis Although cystic fibrosis (CF) isn’t just a ‘lung disease’ – as it affects many parts of the body – it’s important to be aware of the effects CF does have on the lungs.
Our work with the pharmaceutical industry Find out about the Cystic Fibrosis Trust's work with the pharmaceutical industry.
